Cyfuse Biomedical K.K., the Japanese developer of a 3-D printer that produces human tissue, has raised ¥1.4 billion ($11.8 million) from investors including robotic-limb maker Cyberdyne Inc., people familiar with the matter said.
Cyfuse agreed to sell a stake to 12 domestic investors including medical-device manufacturer Shibuya Kogyo Co. and health information provider M3 Inc., the people said, asking not to be identified before a public announcement. In the afternoon, Shibuya Kogyo shares were on track for their biggest gains since Jan. 20.
The company's Regenova three-dimensional printer, developed with Shibuya Kogyo, can be used to turn living cell aggregates into artificial human tissue. Such devices have applications for drugmakers and cosmetics firms seeking to test new products and could eventually be used to cut transplant rejections by constructing organs from a person's own cells.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.